Double Distinction for Ellen Van Obberghen-Shilling
Award
Research
Health
Innovation
Published on December 9, 2024–Updated on February 20, 2025
Dates
on the November 21, 2024
Two new prestigious awards for Ellen Van Obberghen-Shilling (3IA Chairholder)
Ellen Van Obberghen-Shilling (Inserm), 3IA Chairholder, has recently been honored with two prestigious awards.
Ellen Van Obberghen-Shilling, 3IA Chairholder, has recently been honored with two prestigious awards:
The 2024 Cancer Prize from the National Academy of Medicine, recognizing her groundbreaking work on cellular studies of tumors and the role of stromal cells in cancer development.
The 2024 Scientific Grand Prize of the City of Nice, awarded by the Doyen Jean Lépine Committee, in acknowledgment of her pioneering research and significant contributions to the international scientific reputation of the City of Nice.
These distinctions celebrate a remarkable scientific career marked by major advancements in understanding cancer mechanisms.